Premier Biomedical Inc (BIEI)
0.0013
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Premier Biomedical Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2019 | -0.0877 |
| September 30, 2019 | -0.0908 |
| June 30, 2019 | -0.1165 |
| March 31, 2019 | -0.128 |
| December 31, 2018 | -0.1442 |
| Date | Value |
|---|---|
| September 30, 2018 | -0.1356 |
| June 30, 2018 | -0.1077 |
| March 31, 2018 | -0.0803 |
| December 31, 2017 | -0.0651 |
| September 30, 2017 | -0.0373 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1165
Minimum
Jun 2019
-0.0877
Maximum
Dec 2019
-0.0983
Average
-0.0908
Median
Sep 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.1989M |
| Total Liabilities (Quarterly) | 2.126M |
| Shareholders Equity (Quarterly) | -1.927M |